4-electrode ECG (DigitalCardio®) vs Standard 10-electrode ECG: Evaluating Ease of Use and Recording Quality (FAST-ECG)
The goal of this clinical trial is to compare the time required to record a complete Electrocardiogram (ECG) trace using the DigitalCardio (CardioSecur®) tablet device versus a standard 12-lead ECG device in eligible patients.
The main questions it aims to answer are:
Is there a difference in diagnostic recording time (in minutes) between the DigitalCardio tablet and a standard ECG machine? How do the two devices compare in terms of trace quality (including QRS duration, QT interval, frontal axis measurements, and missing/erroneous leads)? How satisfied are healthcare professionals with the CardioSecur® device?
Researchers will compare Group A (standard 10-electrode ECG followed by 4-electrode ECG) to Group B (4-electrode ECG followed by standard 10-electrode ECG) in a 1:1 randomized crossover design to evaluate recording efficiency and trace quality.
Participants will:
Complete an initial screening visit with the principal investigator to review eligibility criteria and sign the informed consent form.
Be randomly assigned (1:1 ratio) to either Group A or Group B. Undergo both ECG recording methods sequentially (a standard 10-electrode ECG and a 4-electrode ECG using the DigitalCardio tablet), while researchers measure the total time elapsed from electrode placement to obtaining a complete trace.
Přehled studie
Postavení
Podmínky
Detailní popis
This study is a randomized, crossover clinical trial designed to compare the efficiency, trace quality, and user satisfaction of a novel 4-electrode tablet-based Electrocardiogram (ECG) system (DigitalCardio / CardioSecur®) against a standard 12-lead (10-electrode) ECG device.
Background and Rationale
An electrocardiogram (ECG) is a fundamental diagnostic tool used to record the electrical activity of the heart. Conventional 12-lead ECGs require placing 10 individual electrodes on a patient's limbs and chest while the patient is lying down. While highly detailed, electrode placement and device setup can be time-consuming in clinical workflows. The DigitalCardio tablet system utilizes a simplified 4-electrode setup designed to streamline data acquisition without compromising diagnostic accuracy.
Study Design and Procedures
After an initial screening process led by the principal investigator, eligible participants receive detailed study information and provide written informed consent. Enrolled participants are then randomly assigned in a 1:1 ratio to one of two sequence groups to control for order effects:
*Group A:Undergoes standard 10-electrode ECG acquisition first, followed immediately by 4-electrode DigitalCardio acquisition.
Group B: Undergoes 4-electrode DigitalCardio acquisition first, followed immediately by standard 10-electrode ECG acquisition.
To maintain consistency, both ECG recordings for a given participant are performed by the same healthcare operator within a minimal time interval.
Key Measurements
- Diagnostic Time:Research staff record the exact time elapsed (in minutes) from the initiation of electrode placement to the successful capture of a complete ECG trace for both devices.
- Trace Quality and Concordance:Printed and anonymized ECG traces are submitted to independent evaluators. Evaluators independently assess trace quality based on standardized criteria, comparing automated measurements (frontal axis, median QRS duration, and QT interval) and counting any missing or erroneous leads.
- Healthcare Professional Satisfaction:Participating healthcare professionals complete a structured questionnaire evaluating user satisfaction and usability of the CardioSecur® device in routine practice.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Bouchra BENKESSOU Chef de projet Recherche Clinique
- Telefonní číslo: +33 7 64 48 60 16
- E-mail: b.benkessou@hexagone-sante-paris.fr
Studijní místa
-
-
-
Paris, Francie, 75016
- Nábor
- Bizet Clinic
-
Kontakt:
- benkessou BOUCHRA
- Telefonní číslo: 0764486016
- E-mail: b.benkessou@cliniques-bltparis.fr
-
Paris, Francie, 75016
- Zatím nenabíráme
- Benkessou
-
Kontakt:
- benkessou BOUCHRA
- Telefonní číslo: 0764486016
- E-mail: b.benkessou@hexagone-sante-paris.fr
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
Hospitalized Cardiology Patients:
- Age minimum 18 years
- Hospitalized for an acute or chronic cardiac condition (e.g., heart failure, acute coronary syndrome, arrhythmia, valvular heart disease, etc.)
- Ability to give informed consent
- Hemodynamic stability permitting the performance of an ECG without clinical risk
Cardiology Outpatients:
- Age minimum of 18 years
- Follow-up for a known cardiac condition or suspected cardiovascular disease
- No contraindications to performing an ECG
- Informed consent obtained
Exclusion Criteria:
- Minor patient (< 18 years of age)
- Adult subject under legal protection, under temporary guardianship, curatorship, or tutelage
- Patient refusing to participate in the study
- Presence of an implantable cardiac device (e.g., pacemaker, defibrillator) that may interfere with ECG measurements
- Severe skin condition preventing the placement of electrodes
- Physical or cognitive inability to follow the study protocol
- Current pregnancy
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Crossover Assignment
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Jiný: standard 10-electrode ECG
Undergoes standard 10-electrode ECG acquisition first
|
Patient undergoes standard 10-electrode ECG acquisition.
Then anonymized ECG traces is printed are submitted to independent evaluators.
Evaluators independently assess trace quality based on standardized criteria, comparing automated measurements (frontal axis, median QRS duration, and QT interval) and counting any missing or erroneous leads.
Followed immediately by 4-electrode DigitalCardio acquisition.
Patient undergoes 4-electrode DigitalCardio acquisition acquisition.
Then anonymized ECG traces is printed are submitted to independent evaluators.
Evaluators independently assess trace quality based on standardized criteria, comparing automated measurements (frontal axis, median QRS duration, and QT interval) and counting any missing or erroneous leads.
Followed immediately by standard 10-electrode ECG acquisition.
|
|
Aktivní komparátor: 4-electrode DigitalCardio
Undergoes 4-electrode DigitalCardio
|
Patient undergoes standard 10-electrode ECG acquisition.
Then anonymized ECG traces is printed are submitted to independent evaluators.
Evaluators independently assess trace quality based on standardized criteria, comparing automated measurements (frontal axis, median QRS duration, and QT interval) and counting any missing or erroneous leads.
Followed immediately by 4-electrode DigitalCardio acquisition.
Patient undergoes 4-electrode DigitalCardio acquisition acquisition.
Then anonymized ECG traces is printed are submitted to independent evaluators.
Evaluators independently assess trace quality based on standardized criteria, comparing automated measurements (frontal axis, median QRS duration, and QT interval) and counting any missing or erroneous leads.
Followed immediately by standard 10-electrode ECG acquisition.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Comparison of Procedure Time Between 4-Electrode DigitalCardio® ECG and Standard 12-Lead ECG
Časové okno: 1 day
|
Time elapsed from the initiation of electrode placement to the obtaining of a complete ECG trace for both the 4-electrode DigitalCardio® system and the standard 12-lead ECG device. Unit of Measure: Minutes |
1 day
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Comparative Quality Assessment of ECG Traces
Časové okno: 1 day
|
Proportion of paired recordings in which an independent cardiologist prefers the 4-electrode DigitalCardio® trace compared to the standard 12-lead ECG trace, based on visual evaluation of signal clarity and the presence of artifacts/interference. Unit of Measure: Percentage of paired recordings |
1 day
|
|
Intraclass Correlation Coefficient (ICC) for Quantitative ECG Parameters
Časové okno: 1 day
|
Degree of agreement for quantitative clinical parameters (e.g., QRS duration, QT interval, frontal axis measurements) automatically provided by both the 4-electrode DigitalCardio® system and the standard 12-lead ECG device. Unit of Measure: Intraclass Correlation Coefficient (ICC) (ranging from 0 to 1, where higher values indicate better agreement) |
1 day
|
|
Diagnostic Concordance for Cardiac Pathology
Časové okno: 1 day
|
Agreement in detecting the presence or absence of cardiac pathology using the 4-electrode DigitalCardio® system compared to the standard 12-lead ECG (gold standard). Unit of Measure: Percentage of concordant diagnostic evaluations |
1 day
|
|
Healthcare Professional Satisfaction Score
Časové okno: 1 days
|
Overall user satisfaction regarding the ease of use of the DigitalCardio® tablet device, evaluated by participating healthcare professionals using a structured Likert scale. The score ranges from 1 (strongly disagree / highly unsatisfied) to 5 (strongly agree / highly satisfied), where higher scores indicate a better outcome (higher satisfaction). Unit of Measure: Score on a scale |
1 days
|
|
Incidence of Device-Related Technical Incidents for 4-electrode DigitalCardio® system
Časové okno: 1 day
|
Total number of technical malfunctions, failures, or operational incidents reported for 4-electrode DigitalCardio® system devices during procedures. And how the issu is been managed. Unit of Measure: Number of technical incidents |
1 day
|
Spolupracovníci a vyšetřovatelé
Sponzor
Publikace a užitečné odkazy
Obecné publikace
- Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29. No abstract available.
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393. No abstract available.
- Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med. 2003 Mar 6;348(10):933-40. doi: 10.1056/NEJMra022700. No abstract available.
- Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction; Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct;33(20):2551-67. doi: 10.1093/eurheartj/ehs184. Epub 2012 Aug 24. No abstract available.
- Nelwan SP, Kors JA, Crater SW, Meij SH, van Dam TB, Simoons ML, Krucoff MW. Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion. J Electrocardiol. 2008 May-Jun;41(3):230-7. doi: 10.1016/j.jelectrocard.2008.01.011.
- Welinder AE, Wagner GS, Horacek BM, Martin TN, Maynard C, Pahlm O. EASI-Derived vs standard 12-lead electrocardiogram for Selvester QRS score estimations of chronic myocardial infarct size, using cardiac magnetic resonance imaging as gold standard. J Electrocardiol. 2009 Mar-Apr;42(2):145-51. doi: 10.1016/j.jelectrocard.2008.10.010. Epub 2008 Dec 18.
- Horacek BM, Warren JW, Penney CJ, MacLeod RS, Title LM, Gardner MJ, Feldman CL. Optimal electrocardiographic leads for detecting acute myocardial ischemia. J Electrocardiol. 2001;34 Suppl:97-111. doi: 10.1054/jelc.2001.28844.
- Martinez JP, Laguna P, Olmos S, Pahlm O, Pettersson J, Sornmo L. Assessment of QT-measurement accuracy using the 12-lead electrocardiogram derived from EASI leads. J Electrocardiol. 2007 Apr;40(2):172-9. doi: 10.1016/j.jelectrocard.2006.08.089. Epub 2006 Oct 6.
- Denes P. The importance of derived 12-lead electrocardiography in the interpretation of arrhythmias detected by Holter recording. Am Heart J. 1992 Oct;124(4):905-11. doi: 10.1016/0002-8703(92)90971-w.
- Drew BJ, Koops RR, Adams MG, Dower GE. Derived 12-lead ECG. Comparison with the standard ECG during myocardial ischemia and its potential application for continuous ST-segment monitoring. J Electrocardiol. 1994;27 Suppl:249-55. doi: 10.1016/s0022-0736(94)80100-2. No abstract available.
- Drew BJ, Ide B. Diagnosing ischemia from the bedside monitor. Prog Cardiovasc Nurs. 1996 Winter;11(1):45-6. No abstract available.
- Schächinger, Volker, Bartosz Przybyla, Pilotstudie zur Detektion von Myokardischämie mit einer auf EASI Standard basierten 3D-Vektor-Eketrokardiographie (CardioSecur), Klinikum Fulda, unpublished
- Okada, Kozo, Comparison of App-based 22-lead electrocardiogram with standard 12-lead electrocardiogram for the diagnosis of acute coronary syndromes, Yokohama City University Medical Center, unpublished
- Johnson H, Duarte N, Ryding D, Perry D, McNally S, Stuart AG, Williams CA, Pieles G. Assessment of a Novel, 22-lead Mobile Electrocardiogram in Elite, Adolescent Footballers. Int J Sports Med. 2022 Mar;43(3):245-253. doi: 10.1055/a-1537-9757. Epub 2021 Aug 13.
- Spaich S, Kern H, Zelniker TA, Stiepak J, Gabel M, Popp E, Katus HA, Preusch MR. Feasibility of CardioSecur(R), a Mobile 4-Electrode/22-Lead ECG Device, in the Prehospital Emergency Setting. Front Cardiovasc Med. 2020 Oct 9;7:551796. doi: 10.3389/fcvm.2020.551796. eCollection 2020.
- De Bie J, Martignani C, Massaro G, Diemberger I. Performance of seven ECG interpretation programs in identifying arrhythmia and acute cardiovascular syndrome. J Electrocardiol. 2020 Jan-Feb;58:143-149. doi: 10.1016/j.jelectrocard.2019.11.043. Epub 2019 Nov 30.
- C.M. Yong, V. Froelicher, G. Wagner L'électrocardiogramme à la croisée des chemins Circulation., 128 (1) (2013), p. 79-82 Voir dans ScopusGoogle Scholar
- D.M.F. Palhares, M.S. Marcolino, T.M.M. Santos, J.L.P. da ilva, P.R. Gomes, L.B. Ribeiro, et al.Limites normales de l'électrocardiogramme dérivées d'une grande base de données de patients brésiliens en soins primaires BMC Cardiovasc Disord, 17 (1) (2017), p. 152 Voir dans ScopusGoogle Scholar
- P.W. Macfarlane, S.M. Lloyd, D. Singh, S. Hamde, E. Clark, B. Devine, et al. Limites normales de l'électrocardiogramme chez les Indiens J Electrocardiol, 48 (4) (2015), p. 652 à 668 Voir le PDF Voir l'articleVoir dans ScopusGoogle Scholar
- Katibi I, Clark EN, Devine B, Lloyd SM, Macfarlane PW. Normal limits of the electrocardiogram in Nigerians. J Electrocardiol. 2013 Jul-Aug;46(4):289-95. doi: 10.1016/j.jelectrocard.2013.04.002. Epub 2013 May 20.
- T.F. Yang, P.W. Macfarlane Nouvelles limites normales dépendantes du sexe de l'électrocardiogramme moyen du signal Br Heart J, 72 (2) (1994), pp. 197-200 Voir sur l'éditeurRéf. croiséeVoir dans ScopusGoogle Scholar
- P.W. Macfarlane, T.D.V. Lawrie L'électrocardiogramme normal et le vectorcardiogramme P.W. Macfarlane, Av Oosterom, O. Pahlm, P. Kligfield, M. Janse, J. Camm (Eds.), Comprehensive Electrocardiology (2. 2 éd.), Springer, Londres (2010), pp. 483-546)
- Wagner GS, Macfarlane P, Wellens H, Josephson M, Gorgels A, Mirvis DM, Pahlm O, Surawicz B, Kligfield P, Childers R, Gettes LS, Bailey JJ, Deal BJ, Gorgels A, Hancock EW, Kors JA, Mason JW, Okin P, Rautaharju PM, van Herpen G; American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009 Mar 17;53(11):1003-11. doi: 10.1016/j.jacc.2008.12.016. No abstract available.
- Bayés de Luna, A., Wagner, G. S., Birnbaum, Y., Nikus, K., Fiol, M., Gorgels, A., Pahlm, O., & Sclarovsky, S. (2008). A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of the American Heart Association Committee on Electrocardiography and the Cardiac Mapping Committee of the International Society for Holter and Noninvasive Electrocardiology. Journal of Electrocardiology, 41(4), 342-347. DOI: 10.1016/j.jelectrocard.2008.02.008
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 2026-A00856-45
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .